Skip to main content

Study Quantifies Breast Shrinkage After T1 Tumor Lumpectomy

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 4, 2025.

via HealthDay

FRIDAY, April 4, 2025 -- Patients with T1 tumors undergoing breast-conserving therapy/radiation therapy (BCT/RT) may lose about 20 percent of breast volume at one year, according to a study published in the April issue of Plastic and Reconstructive Surgery.

Miriam Becker, from the University of California in San Diego, and colleagues calculated breast volume changes for 113 patients (115 breasts) after T1 tumor lumpectomies. Volumes were calculated from mammograms from preoperative baseline to seven years after radiation. Changes over time were assessed, with subset analyses of tumor volume of the breast of 10 percent or less and greater than 10 percent (67 and 48 patients, respectively).

During surgery, patients lost 8.3 percent of breast volume. The researchers found that volume loss was 19.3 percent at one year after BCT/RT. Total volume loss was 26.6 percent by year 5. In addition to lumpectomy defects, five-year volume loss was 21.7 and 29.5 percent for tumor/breast volume greater than 10 percent or 10 percent or less, respectively. No significant difference was seen for volume loss between subgroups. Larger breast volume was a significant predictor of greater volume loss for all five years, followed by diabetes and smoking history.

"Larger breast size, diabetes, and smoking history may predict increased volume loss whether whole- or partial-breast radiation was administered, and treatment with cytotoxic chemotherapy may predict increased shrinkage in patients receiving whole-breast radiation," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

AI Support Improves Breast Cancer Detection Accuracy in Mammography

MONDAY, July 14, 2025 -- Artificial intelligence (AI) support improves radiologists' breast cancer detection accuracy when reading mammograms, according to a study published...

Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer

FRIDAY, July 11, 2025 -- Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients diagnosed with pancreatic cancer...

Radiation Therapy Can Promote Amphiregulin, Which Increases Growth of Metastases

THURSDAY, July 10, 2025 -- Radiation therapy can promote the epidermal growth factor receptor (EGFR) ligand amphiregulin, which increases growth of existing metastases in patients...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.